25 XP   0   0   10

ASTRAZENECA PHARMA INDIA LTD.
Buy, Hold or Sell?

Let's analyse ASTRAZENECA PHARMA INDIA LTD. together

PenkeI guess you are interested in ASTRAZENECA PHARMA INDIA LTD.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of ASTRAZENECA PHARMA INDIA LTD.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about ASTRAZENECA PHARMA INDIA LTD.

I send you an email if I find something interesting about ASTRAZENECA PHARMA INDIA LTD..

Quick analysis of ASTRAZENECA PHARMA INDIA LTD. (30 sec.)










What can you expect buying and holding a share of ASTRAZENECA PHARMA INDIA LTD.? (30 sec.)

How much money do you get?

How much money do you get?
INR0.38
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
INR235.48
Expected worth in 1 year
INR359.16
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
INR155.68
Return On Investment
3.2%

For what price can you sell your share?

Current Price per Share
INR4,809.50
Expected price per share
INR4,501 - INR5,001
How sure are you?
50%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1. Valuation of ASTRAZENECA PHARMA INDIA LTD. (5 min.)




Live pricePrice per Share (EOD)

INR4,809.50

Intrinsic Value Per Share

INR89.19 - INR440.28

Total Value Per Share

INR324.67 - INR675.76

2. Growth of ASTRAZENECA PHARMA INDIA LTD. (5 min.)




Is ASTRAZENECA PHARMA INDIA LTD. growing?

Current yearPrevious yearGrowGrow %
How rich?$70.6m$61.3m$9.2m13.1%

How much money is ASTRAZENECA PHARMA INDIA LTD. making?

Current yearPrevious yearGrowGrow %
Making money$11.9m$7.3m$4.5m38.0%
Net Profit Margin9.9%7.6%--

How much money comes from the company's main activities?

3. Financial Health of ASTRAZENECA PHARMA INDIA LTD. (5 min.)




3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

What can you expect buying and holding a share of ASTRAZENECA PHARMA INDIA LTD.? (5 min.)

Welcome investor! ASTRAZENECA PHARMA INDIA LTD.'s management wants to use your money to grow the business. In return you get a share of ASTRAZENECA PHARMA INDIA LTD..

What can you expect buying and holding a share of ASTRAZENECA PHARMA INDIA LTD.?

First you should know what it really means to hold a share of ASTRAZENECA PHARMA INDIA LTD.. And how you can make/lose money.

Speculation

The Price per Share of ASTRAZENECA PHARMA INDIA LTD. is INR4,810. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of ASTRAZENECA PHARMA INDIA LTD..
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in ASTRAZENECA PHARMA INDIA LTD., you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR235.48. Based on the TTM, the Book Value Change Per Share is INR30.92 per quarter. Based on the YOY, the Book Value Change Per Share is INR22.09 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR8.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of ASTRAZENECA PHARMA INDIA LTD..

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.480.0%0.480.0%0.300.0%0.370.0%0.290.0%
Usd Book Value Change Per Share0.370.0%0.370.0%0.270.0%0.330.0%0.400.0%
Usd Dividend Per Share0.100.0%0.100.0%0.020.0%0.030.0%0.030.0%
Usd Total Gains Per Share0.470.0%0.470.0%0.290.0%0.360.0%0.430.0%
Usd Price Per Share39.51-39.51-37.20-36.21-29.45-
Price to Earnings Ratio82.90-82.90-125.83-98.01-102.54-
Price-to-Total Gains Ratio84.60-84.60-128.71-99.26-88.03-
Price to Book Ratio13.98-13.98-15.16-16.91-15.24-
Price-to-Total Gains Ratio84.60-84.60-128.71-99.26-88.03-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share57.714
Number of shares17
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.100.03
Usd Book Value Change Per Share0.370.33
Usd Total Gains Per Share0.470.36
Gains per Quarter (17 shares)7.946.15
Gains per Year (17 shares)31.7624.59
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
17252222215
213505454540
320768676765
42610111898990
53312615011112115
63915118214134140
74617721416156165
85220224618178190
95922727821201215
106525231023223240

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

Fundamentals of ASTRAZENECA PHARMA INDIA LTD.

About ASTRAZENECA PHARMA INDIA LTD.

  • 947

AstraZeneca Pharma India Limited, a biopharmaceutical company, engages in manufacturing, distributing, and marketing of pharmaceutical products in India and internationally. It manufactures and sells cardiovascular disease and diabetes medicines under the Brilinta, Betaloc, Crestor, Forxiga, Imdur, Kombiglyze XR, Onglyza, Seloken XL, Xigduo XR, and QTERN brand names; Respiratory medicines under the Symbicort and FASENRA brand names; and oncology medicines under the LYNPARZA, Tagrisso, Iressa, Calquence, Casodex, Faslodex, Zoladex, and Arimidex brand names. The company also offers products in the areas of renal, metabolic, and immunology diseases. It also provides clinical trial services. The company was incorporated in 1979 and is based in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.

Fundamental data was last updated by Penke on 2023-12-01 16:51:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.1. Profitability of ASTRAZENECA PHARMA INDIA LTD..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit ASTRAZENECA PHARMA INDIA LTD. earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare ASTRAZENECA PHARMA INDIA LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 9.9% means that ₹0.10 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of ASTRAZENECA PHARMA INDIA LTD.:

  • The MRQ is 9.9%. The company is making a profit. +1
  • The TTM is 9.9%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ9.9%TTM9.9%0.0%
TTM9.9%YOY7.6%+2.3%
TTM9.9%5Y9.0%+0.9%
5Y9.0%10Y7.6%+1.4%
1.1.2. Return on Assets

Shows how efficient ASTRAZENECA PHARMA INDIA LTD. is using its assets to generate profit.

  • Above 5% is considered healthy but always compare ASTRAZENECA PHARMA INDIA LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • 10.1% Return on Assets means that ASTRAZENECA PHARMA INDIA LTD. generated ₹0.10 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of ASTRAZENECA PHARMA INDIA LTD.:

  • The MRQ is 10.1%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 10.1%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ10.1%TTM10.1%0.0%
TTM10.1%YOY7.2%+2.9%
TTM10.1%5Y9.8%+0.2%
5Y9.8%10Y8.5%+1.3%
1.1.3. Return on Equity

Shows how efficient ASTRAZENECA PHARMA INDIA LTD. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare ASTRAZENECA PHARMA INDIA LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • 16.9% Return on Equity means ASTRAZENECA PHARMA INDIA LTD. generated ₹0.17 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of ASTRAZENECA PHARMA INDIA LTD.:

  • The MRQ is 16.9%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 16.9%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ16.9%TTM16.9%0.0%
TTM16.9%YOY12.0%+4.8%
TTM16.9%5Y17.5%-0.6%
5Y17.5%10Y15.3%+2.2%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.2. Operating Efficiency of ASTRAZENECA PHARMA INDIA LTD..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient ASTRAZENECA PHARMA INDIA LTD. is operating .

  • Measures how much profit ASTRAZENECA PHARMA INDIA LTD. makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare ASTRAZENECA PHARMA INDIA LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of ASTRAZENECA PHARMA INDIA LTD.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y4.0%-4.0%
5Y4.0%10Y4.5%-0.5%
1.2.2. Operating Ratio

Measures how efficient ASTRAZENECA PHARMA INDIA LTD. is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.38 means that the operating costs are ₹1.38 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of ASTRAZENECA PHARMA INDIA LTD.:

  • The MRQ is 1.379. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.379. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.379TTM1.3790.000
TTM1.379YOY1.367+0.011
TTM1.3795Y1.321+0.058
5Y1.32110Y1.058+0.263
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.3. Liquidity of ASTRAZENECA PHARMA INDIA LTD..

1.3. Liquidity
1.3.1. Current Ratio

Measures if ASTRAZENECA PHARMA INDIA LTD. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.18 means the company has ₹2.18 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of ASTRAZENECA PHARMA INDIA LTD.:

  • The MRQ is 2.176. The company is able to pay all its short-term debts. +1
  • The TTM is 2.176. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.176TTM2.1760.000
TTM2.176YOY2.121+0.055
TTM2.1765Y1.911+0.265
5Y1.91110Y1.776+0.136
1.3.2. Quick Ratio

Measures if ASTRAZENECA PHARMA INDIA LTD. is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare ASTRAZENECA PHARMA INDIA LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.58 means the company can pay off ₹1.58 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of ASTRAZENECA PHARMA INDIA LTD.:

  • The MRQ is 1.584. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.584. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.584TTM1.5840.000
TTM1.584YOY1.607-0.023
TTM1.5845Y1.446+0.137
5Y1.44610Y1.302+0.145
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.4. Solvency of ASTRAZENECA PHARMA INDIA LTD..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of ASTRAZENECA PHARMA INDIA LTD. assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare ASTRAZENECA PHARMA INDIA LTD. to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.40 means that ASTRAZENECA PHARMA INDIA LTD. assets are financed with 40.2% credit (debt) and the remaining percentage (100% - 40.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of ASTRAZENECA PHARMA INDIA LTD.:

  • The MRQ is 0.402. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.402. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.402TTM0.4020.000
TTM0.402YOY0.403-0.001
TTM0.4025Y0.433-0.031
5Y0.43310Y0.442-0.009
1.4.2. Debt to Equity Ratio

Measures if ASTRAZENECA PHARMA INDIA LTD. is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare ASTRAZENECA PHARMA INDIA LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 67.3% means that company has ₹0.67 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of ASTRAZENECA PHARMA INDIA LTD.:

  • The MRQ is 0.673. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.673. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.673TTM0.6730.000
TTM0.673YOY0.675-0.002
TTM0.6735Y0.770-0.097
5Y0.77010Y0.797-0.027
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

2. Market Valuation of ASTRAZENECA PHARMA INDIA LTD.

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings ASTRAZENECA PHARMA INDIA LTD. generates.

  • Above 15 is considered overpriced but always compare ASTRAZENECA PHARMA INDIA LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 82.90 means the investor is paying ₹82.90 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of ASTRAZENECA PHARMA INDIA LTD.:

  • The EOD is 121.097. Based on the earnings, the company is expensive. -2
  • The MRQ is 82.900. Based on the earnings, the company is expensive. -2
  • The TTM is 82.900. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD121.097MRQ82.900+38.197
MRQ82.900TTM82.9000.000
TTM82.900YOY125.826-42.926
TTM82.9005Y98.007-15.107
5Y98.00710Y102.538-4.531
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of ASTRAZENECA PHARMA INDIA LTD.:

  • The EOD is 241.547. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 165.356. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 165.356. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD241.547MRQ165.356+76.191
MRQ165.356TTM165.3560.000
TTM165.356YOY85.006+80.350
TTM165.3565Y111.799+53.557
5Y111.79910Y255.775-143.976
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of ASTRAZENECA PHARMA INDIA LTD. is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 13.98 means the investor is paying ₹13.98 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of ASTRAZENECA PHARMA INDIA LTD.:

  • The EOD is 20.425. Based on the equity, the company is expensive. -2
  • The MRQ is 13.982. Based on the equity, the company is expensive. -2
  • The TTM is 13.982. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD20.425MRQ13.982+6.442
MRQ13.982TTM13.9820.000
TTM13.982YOY15.156-1.174
TTM13.9825Y16.905-2.923
5Y16.90510Y15.242+1.663
2. Total Gains per Share
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

3. Summary

3.1. Key Performance Indicators

The key performance indicators of ASTRAZENECA PHARMA INDIA LTD. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--30.92030.9200%22.088+40%27.341+13%33.639-8%
Book Value Per Share--235.476235.4760%204.556+15%177.719+32%153.788+53%
Current Ratio--2.1762.1760%2.121+3%1.911+14%1.776+23%
Debt To Asset Ratio--0.4020.4020%0.4030%0.433-7%0.442-9%
Debt To Equity Ratio--0.6730.6730%0.6750%0.770-13%0.797-16%
Dividend Per Share--8.0008.0000%2.000+300%2.800+186%2.286+250%
Eps--39.71639.7160%24.640+61%30.468+30%24.389+63%
Free Cash Flow Per Share--19.91119.9110%36.472-45%27.801-28%21.856-9%
Free Cash Flow To Equity Per Share--10.11910.1190%32.688-69%23.351-57%17.950-44%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--440.280--------
Intrinsic Value_10Y_min--89.190--------
Intrinsic Value_1Y_max--34.484--------
Intrinsic Value_1Y_min--23.282--------
Intrinsic Value_3Y_max--110.954--------
Intrinsic Value_3Y_min--57.942--------
Intrinsic Value_5Y_max--196.277--------
Intrinsic Value_5Y_min--79.176--------
Market Cap120237500000.000+32%82311250000.00082311250000.0000%77508750000.000+6%75446250000.000+9%61353928571.429+34%
Net Profit Margin--0.0990.0990%0.076+29%0.090+10%0.076+30%
Operating Margin----0%-0%0.040-100%0.045-100%
Operating Ratio--1.3791.3790%1.367+1%1.321+4%1.058+30%
Pb Ratio20.425+32%13.98213.9820%15.156-8%16.905-17%15.242-8%
Pe Ratio121.097+32%82.90082.9000%125.826-34%98.007-15%102.538-19%
Price Per Share4809.500+32%3292.4503292.4500%3100.350+6%3017.850+9%2454.157+34%
Price To Free Cash Flow Ratio241.547+32%165.356165.3560%85.006+95%111.799+48%255.775-35%
Price To Total Gains Ratio123.574+32%84.59584.5950%128.709-34%99.258-15%88.027-4%
Quick Ratio--1.5841.5840%1.607-1%1.446+9%1.302+22%
Return On Assets--0.1010.1010%0.072+40%0.098+2%0.085+18%
Return On Equity--0.1690.1690%0.120+40%0.175-3%0.153+11%
Total Gains Per Share--38.92038.9200%24.088+62%30.141+29%35.925+8%
Usd Book Value--70642800.00070642800.0000%61366800.000+15%53315760.000+32%46136400.000+53%
Usd Book Value Change Per Share--0.3710.3710%0.265+40%0.328+13%0.404-8%
Usd Book Value Per Share--2.8262.8260%2.455+15%2.133+32%1.845+53%
Usd Dividend Per Share--0.0960.0960%0.024+300%0.034+186%0.027+250%
Usd Eps--0.4770.4770%0.296+61%0.366+30%0.293+63%
Usd Free Cash Flow--5973372.0005973372.0000%10941600.000-45%8340434.400-28%6556767.429-9%
Usd Free Cash Flow Per Share--0.2390.2390%0.438-45%0.334-28%0.262-9%
Usd Free Cash Flow To Equity Per Share--0.1210.1210%0.392-69%0.280-57%0.215-44%
Usd Market Cap1442850000.000+32%987735000.000987735000.0000%930105000.000+6%905355000.000+9%736247142.857+34%
Usd Price Per Share57.714+32%39.50939.5090%37.204+6%36.214+9%29.450+34%
Usd Profit--11914800.00011914800.0000%7392000.000+61%9140400.000+30%7316742.857+63%
Usd Revenue--120356400.000120356400.0000%96672000.000+24%100373520.000+20%90906514.286+32%
Usd Total Gains Per Share--0.4670.4670%0.289+62%0.362+29%0.431+8%
 EOD+4 -4MRQTTM+0 -0YOY+24 -105Y+24 -1110Y+24 -11

3.2. Fundamental Score

Let's check the fundamental score of ASTRAZENECA PHARMA INDIA LTD. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15121.097
Price to Book Ratio (EOD)Between0-120.425
Net Profit Margin (MRQ)Greater than00.099
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.584
Current Ratio (MRQ)Greater than12.176
Debt to Asset Ratio (MRQ)Less than10.402
Debt to Equity Ratio (MRQ)Less than10.673
Return on Equity (MRQ)Greater than0.150.169
Return on Assets (MRQ)Greater than0.050.101
Total7/10 (70.0%)

3.3. Technical Score

Let's check the technical score of ASTRAZENECA PHARMA INDIA LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5060.197
Ma 20Greater thanMa 504,718.367
Ma 50Greater thanMa 1004,662.812
Ma 100Greater thanMa 2004,364.121
OpenGreater thanClose4,869.950
Total5/5 (100.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-12-312019-12-312020-12-312021-12-312022-12-31
Net Interest Income  153,700-42,800110,900-17,20093,70011,600105,300-111,632-6,332



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in INR. All numbers in thousands.

Summary
Total Assets9,848,700
Total Liabilities3,961,800
Total Stockholder Equity5,886,900
 As reported
Total Liabilities 3,961,800
Total Stockholder Equity+ 5,886,900
Total Assets = 9,848,700

Assets

Total Assets9,848,700
Total Current Assets8,354,700
Long-term Assets8,354,700
Total Current Assets
Cash And Cash Equivalents 25,000
Short-term Investments 600
Net Receivables 1,075,200
Inventory 1,906,600
Other Current Assets 1,400
Total Current Assets  (as reported)8,354,700
Total Current Assets  (calculated)3,008,800
+/- 5,345,900
Long-term Assets
Property Plant Equipment 701,900
Other Assets 206,700
Long-term Assets  (as reported)1,493,961
Long-term Assets  (calculated)908,600
+/- 585,361

Liabilities & Shareholders' Equity

Total Current Liabilities3,839,300
Long-term Liabilities122,553
Total Stockholder Equity5,886,900
Total Current Liabilities
Accounts payable 2,278,766
Other Current Liabilities 780,630
Total Current Liabilities  (as reported)3,839,300
Total Current Liabilities  (calculated)3,059,396
+/- 779,904
Long-term Liabilities
Long term Debt Total 36,900
Capital Lease Obligations Min Short Term Debt72,136
Long-term Liabilities  (as reported)122,553
Long-term Liabilities  (calculated)109,036
+/- 13,517
Total Stockholder Equity
Common Stock50,000
Retained Earnings 5,811,200
Total Stockholder Equity (as reported)5,886,900
Total Stockholder Equity (calculated)5,861,200
+/- 25,700
Other
Capital Stock50,000
Cash And Equivalents4,978,400
Cash and Short Term Investments 5,004,000
Common Stock Shares Outstanding 25,000
Liabilities and Stockholders Equity 9,848,700
Net Invested Capital 5,886,883
Net Working Capital 4,515,475



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
> Total Assets 
4,154,900
4,605,400
5,618,000
7,063,600
7,747,100
8,565,600
9,848,700
9,848,7008,565,6007,747,1007,063,6005,618,0004,605,4004,154,900
   > Total Current Assets 
2,515,500
3,209,200
4,047,200
5,423,200
6,187,600
7,056,700
8,354,700
8,354,7007,056,7006,187,6005,423,2004,047,2003,209,2002,515,500
       Cash And Cash Equivalents 
1,132,300
1,094,500
1,683,600
818,000
30,100
88,200
25,000
25,00088,20030,100818,0001,683,6001,094,5001,132,300
       Short-term Investments 
6,100
116,800
0
1,690,000
56,560
900
600
60090056,5601,690,0000116,8006,100
       Net Receivables 
609,500
594,100
861,200
955,800
851,900
858,900
1,075,200
1,075,200858,900851,900955,800861,200594,100609,500
       Inventory 
577,100
1,131,500
1,181,000
1,651,500
1,601,800
1,413,200
1,906,600
1,906,6001,413,2001,601,8001,651,5001,181,0001,131,500577,100
       Other Current Assets 
109,200
157,500
198,800
208,100
100
400
1,400
1,400400100208,100198,800157,500109,200
   > Long-term Assets 
0
0
1,570,800
1,640,400
1,559,500
1,508,900
1,493,961
1,493,9611,508,9001,559,5001,640,4001,570,80000
       Property Plant Equipment 
916,500
790,300
817,300
957,700
849,800
766,900
701,900
701,900766,900849,800957,700817,300790,300916,500
       Long-term Assets Other 
0
0
6,000
-1,158,400
20,135
29,903
30,927
30,92729,90320,135-1,158,4006,00000
> Total Liabilities 
1,926,200
2,136,100
2,610,000
3,419,200
3,185,400
3,451,700
3,961,800
3,961,8003,451,7003,185,4003,419,2002,610,0002,136,1001,926,200
   > Total Current Liabilities 
1,903,400
2,069,500
2,589,800
3,272,400
3,035,000
3,326,500
3,839,300
3,839,3003,326,5003,035,0003,272,4002,589,8002,069,5001,903,400
       Accounts payable 
876,600
1,272,000
1,682,000
2,097,200
1,783,700
1,880,600
2,278,766
2,278,7661,880,6001,783,7002,097,2001,682,0001,272,000876,600
       Other Current Liabilities 
300,900
229,500
219,200
196,200
136,500
154,600
780,630
780,630154,600136,500196,200219,200229,500300,900
   > Long-term Liabilities 
0
0
20,200
146,800
150,400
125,200
122,553
122,553125,200150,400146,80020,20000
       Long term Debt Total 
0
0
0
93,000
86,300
50,200
36,900
36,90050,20086,30093,000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
118,400
121,400
86,300
72,136
72,13686,300121,400118,400000
> Total Stockholder Equity
2,228,700
2,469,300
3,008,000
3,644,400
4,561,700
5,113,900
5,886,900
5,886,9005,113,9004,561,7003,644,4003,008,0002,469,3002,228,700
   Common Stock
50,000
50,000
50,000
50,000
50,000
50,000
50,000
50,00050,00050,00050,00050,00050,00050,000
   Retained Earnings 
1,438,700
1,675,000
2,213,500
2,855,000
4,495,800
5,044,400
5,811,200
5,811,2005,044,4004,495,8002,855,0002,213,5001,675,0001,438,700
   Capital Surplus 0000000
   Treasury Stock0000000
   Other Stockholders Equity 
740,000
744,300
744,500
739,400
0
0
0
000739,400744,500744,300740,000



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue10,029,700
Cost of Revenue-4,308,000
Gross Profit5,721,7005,721,700
 
Operating Income (+$)
Gross Profit5,721,700
Operating Expense-9,518,217
Operating Income1,086,300-3,796,517
 
Operating Expense (+$)
Research Development0
Selling General Administrative3,971,600
Selling And Marketing Expenses0
Operating Expense9,518,2173,971,600
 
Net Interest Income (+$)
Interest Income227,700
Interest Expense-6,332
Other Finance Cost-227,700
Net Interest Income-6,332
 
Pretax Income (+$)
Operating Income1,086,300
Net Interest Income-6,332
Other Non-Operating Income Expenses0
Income Before Tax (EBT)1,341,0001,086,300
EBIT - interestExpense = -6,332
992,900
999,232
Interest Expense6,332
Earnings Before Interest and Taxes (EBIT)01,347,332
Earnings Before Interest and Taxes (EBITDA)1,509,980
 
After tax Income (+$)
Income Before Tax1,341,000
Tax Provision-348,100
Net Income From Continuing Ops992,926992,900
Net Income992,900
Net Income Applicable To Common Shares992,900
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net06,332
 

Technical Analysis of ASTRAZENECA PHARMA INDIA LTD.
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of ASTRAZENECA PHARMA INDIA LTD.. The general trend of ASTRAZENECA PHARMA INDIA LTD. is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine ASTRAZENECA PHARMA INDIA LTD.'s overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of ASTRAZENECA PHARMA INDIA LTD..

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 5,001.

The bearish price targets are: 4,575 > 4,542 > 4,501.

Tweet this
ASTRAZENECA PHARMA INDIA LTD. Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of ASTRAZENECA PHARMA INDIA LTD.. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

ASTRAZENECA PHARMA INDIA LTD. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of ASTRAZENECA PHARMA INDIA LTD.. The current macd is 42.12.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the ASTRAZENECA PHARMA INDIA LTD. price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for ASTRAZENECA PHARMA INDIA LTD.. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the ASTRAZENECA PHARMA INDIA LTD. price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
ASTRAZENECA PHARMA INDIA LTD. Daily Moving Average Convergence/Divergence (MACD) ChartASTRAZENECA PHARMA INDIA LTD. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of ASTRAZENECA PHARMA INDIA LTD.. The current adx is 22.27.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy ASTRAZENECA PHARMA INDIA LTD. shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
ASTRAZENECA PHARMA INDIA LTD. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of ASTRAZENECA PHARMA INDIA LTD.. The current sar is 4,888.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
ASTRAZENECA PHARMA INDIA LTD. Daily Parabolic SAR Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of ASTRAZENECA PHARMA INDIA LTD.. The current rsi is 60.20. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
ASTRAZENECA PHARMA INDIA LTD. Daily Relative Strength Index (RSI) ChartASTRAZENECA PHARMA INDIA LTD. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of ASTRAZENECA PHARMA INDIA LTD.. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the ASTRAZENECA PHARMA INDIA LTD. price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
ASTRAZENECA PHARMA INDIA LTD. Daily Stochastic Oscillator ChartASTRAZENECA PHARMA INDIA LTD. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of ASTRAZENECA PHARMA INDIA LTD.. The current cci is 99.56.

ASTRAZENECA PHARMA INDIA LTD. Daily Commodity Channel Index (CCI) ChartASTRAZENECA PHARMA INDIA LTD. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of ASTRAZENECA PHARMA INDIA LTD.. The current cmo is 27.09.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
ASTRAZENECA PHARMA INDIA LTD. Daily Chande Momentum Oscillator (CMO) ChartASTRAZENECA PHARMA INDIA LTD. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of ASTRAZENECA PHARMA INDIA LTD.. The current willr is -24.22043999.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that ASTRAZENECA PHARMA INDIA LTD. is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
ASTRAZENECA PHARMA INDIA LTD. Daily Williams %R ChartASTRAZENECA PHARMA INDIA LTD. Daily Williams %R Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of ASTRAZENECA PHARMA INDIA LTD..

ASTRAZENECA PHARMA INDIA LTD. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of ASTRAZENECA PHARMA INDIA LTD.. The current atr is 117.23.

ASTRAZENECA PHARMA INDIA LTD. Daily Average True Range (ATR) ChartASTRAZENECA PHARMA INDIA LTD. Daily Average True Range (ATR) Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of ASTRAZENECA PHARMA INDIA LTD.. The current obv is -49,760.

ASTRAZENECA PHARMA INDIA LTD. Daily On-Balance Volume (OBV) ChartASTRAZENECA PHARMA INDIA LTD. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of ASTRAZENECA PHARMA INDIA LTD.. The current mfi is 92.63.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
ASTRAZENECA PHARMA INDIA LTD. Daily Money Flow Index (MFI) ChartASTRAZENECA PHARMA INDIA LTD. Daily Money Flow Index (MFI) Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for ASTRAZENECA PHARMA INDIA LTD..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-07-13CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-07-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-07-17STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-07-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-07-20STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-07-21RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-07-25STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-07-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-07-28STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-07-31STOCH LONG EXITThe %K line crosses below the %D line.
2023-08-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-08-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-08-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-08-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-08-09STOCH LONG EXITThe %K line crosses below the %D line.
2023-08-10SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-08-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-08-17STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-08-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-08-24RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-08-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-08-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-08-30CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-09-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-09-05STOCH SHORT EXITThe %K line crosses above the %D line.
2023-09-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-09-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-09-11BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-09-12STOCH LONG EXITThe %K line crosses below the %D line.
2023-09-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-09-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-09-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-09-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-09-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-09-25RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-09-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-09-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-09-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-10-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-10-05STOCH SHORT EXITThe %K line crosses above the %D line.
2023-10-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-10-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-10-10STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-10-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-10-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-10-16STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-10-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-10-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-10-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-10-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-10-25STOCH SHORT EXITThe %K line crosses above the %D line.
2023-10-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-10-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-10-31STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-03STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-11-07CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-08WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-11-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-16STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-17STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-23STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-01CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside

6.3. Candlestick Patterns

ASTRAZENECA PHARMA INDIA LTD. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of ASTRAZENECA PHARMA INDIA LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5060.197
Ma 20Greater thanMa 504,718.367
Ma 50Greater thanMa 1004,662.812
Ma 100Greater thanMa 2004,364.121
OpenGreater thanClose4,869.950
Total5/5 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of ASTRAZENECA PHARMA INDIA LTD. with someone you think should read this too:
  • Are you bullish or bearish on ASTRAZENECA PHARMA INDIA LTD.? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about ASTRAZENECA PHARMA INDIA LTD.? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about ASTRAZENECA PHARMA INDIA LTD.

I send you an email if I find something interesting about ASTRAZENECA PHARMA INDIA LTD..


Comments

How you think about this?

Leave a comment
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

Stay informed about ASTRAZENECA PHARMA INDIA LTD..

Receive notifications about ASTRAZENECA PHARMA INDIA LTD. in your mailbox!